Off the agenda
Diagnostics company Agendia pulls Euronext IPO, citing market volatility
Off the agenda
Molecular diagnostics play Agendia B.V. was slated for an IPO last week, but instead it pulled
Gathering data...
Molecular diagnostics play Agendia B.V. was slated for an IPO last week, but instead it pulled